Industry Insights

31. Extraction And Chemical Characterization Pitfalls In Complex Medical Devices 8/20/2026

    Standard extraction protocols routinely fail tissue-derived products, hydrogels, absorbables, and silicone implants. Learn the material-specific study design strategies that prevent regulatory rejection and repeat work.

32. Running Compliant Studies Without Enterprise EDC Overhead 8/19/2026

    Low-complexity medical device and IVD studies often fall between enterprise EDC systems and spreadsheets. This webinar shows how a compliant, audit-ready alternative works in practice.

33. From Hype To Health: The Three Jobs Sword Made Its Clinical Evidence Do 8/19/2026

    A long-term strategy for turning clinical evidence into clinician trust, standard-of-care status, and payer reimbursement for digital care.

34. Don't Lose Sight Of Ophthalmic Injectables' Regulatory Complexity 8/17/2026

    Intravitreal injectables face some of the strictest regulatory scrutiny in drug development. Learn what sponsors need to know about EU GMP Annex 1, USP standards, and container closure integrity to stay compliant.

35. The Right Sized Medical Manufacturer 8/17/2026

    Medbio combines tooling, molding, automation, assembly, packaging, and quality support to help medical manufacturers reduce complexity, manage risk, and move programs efficiently toward production.

36. Ophthalmic Drug Delivery: Meeting Modern Challenges With A Next Generation Solution 8/17/2026

    Ophthalmic injectable packaging demands early strategic attention. Learn how silicone oil contamination, particulate limits, and dosing accuracy challenges can derail development programs and what it takes to stay compliant.

37. The Clear Solution: Navigating Contamination Control For Ophthalmic Injectables 8/12/2026

    As the intravitreal therapy market grows and applicable regulations evolve, continued compliance demands technological savvy and rigorous contamination control.

38. Understanding Ethylene Oxide Residual Behavior 8/12/2026

    EtO sterilization leaves residuals that can delay device release and create compliance risk. Learn what drives absorption and desorption across materials, geometry, and process conditions under ISO 10993-7.

39. EtO Residual Testing Under ISO 10993-7:2026 8/12/2026

    ISO 10993-7:2026 ties EtO and ECH residual limits directly to patient exposure, not just material levels. Understand the TI, TE, and AL framework before your next sterilization validation.

40. When Plastic Meets Metal At The Micron Level 8/10/2026

    Micro insert molding enables smaller, more integrated medical devices—but reliable polymer-metal interfaces require precise insert handling, material selection, positional control, and validation.